Becton, Dickinson & Co. EO-Notes 2024(24/31)
- BID
99.754
- ASK
99.973
- 500,000 Nom.500,000 Nom.
- 07/28, 12:42:25 PM
Type of financial instrument
Corporate Bond
Sub-Type
Health Care
Yield
3.57
Yield spread Bundesanleihe
0.6697
Tradable for private investors
No
Minimum amount tradeable unit
100,000.00
Maturity
08/02/2031
Interest Rate
3.519 %
Currency
Euro
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE / YIELD | 99.781 G / 3.57 | 0 Units |
| PRICE DETERMINATION TIME | 07/28/2026 / 12:06:15 PM | |
| DAILY VOLUME (NOMINAL) | 0 | |
| YIELD SPREAD | 0.6697 | |
| FIXINGPRICE | - | |
| DAILY HIGH / LOW | 99.824 | 99.683 |
| PREV. DAY'S PRICE | 99.687 | (07/27) |
| CHANGE DAY BEFORE | +0.09 | 0.09 % |
| 52 WEEK HIGH / LOW | 102.765 (10/16) | 98.755 (03/23) |
Master Data
| WKN | A3LUHG |
| ISIN | XS2763026395 |
| SYMBOL | - |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Corporate Bond |
| SUB-TYPE | Health Care |
| ISSUER | Becton Dickinson & Co. |
| S&P RATING | Please log in to view this field |
| (TRADING) SEGMENT / TICKS | -/ - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| INTEREST RATE | 3.519 % |
| INTEREST RUN FROM | 08/02/2024 |
| NEXT INTEREST PAYMENT | 08/02/2027 |
| UNIT INTEREST FROM NOMINAL AMMOUNT | 1.658 % |
| TRADING CURRENCY / NOTATION | Euro/ Percent |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| QUOTATION | Continuous trading |
| ISSUING VOLUME | 750.00 Mil. |
| MINIMUM AMOUNT TRADEABLE UNIT | 100,000.00 |
| SMALLEST TRADEABLE UNIT | 1,000.00 |
| MATURITY | 08/02/2031 |
| MARKET MAKER | - |
| STEP UP/ DOWN WHEN RATING CHANGES | No |
| STEP UP FIXED AT ISSUE | No |
| STEP DOWN FIXED AT ISSUE | No |
| BOND CALLABLE BY THE ISSUER | Yes |
| BOND IS SUBORDINATED | No |
Description
Make Whole Call Option. Callable bond.
Tradability Information
Please log in to see the tradability information for this stock.Not registered yet? Create your free account here.
Company profile
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.